FSA
CRSP icon

Fort Sheridan Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,829
Closed -$296K 197
2021
Q2
$296K Buy
1,829
+100
+6% +$16.2K 0.1% 136
2021
Q1
$211K Buy
1,729
+272
+19% +$33.2K 0.08% 147
2020
Q4
$223K Buy
+1,457
New +$223K 0.11% 109